scholarly journals UCE6, a New Antitumor Antibiotic with Topoisomerase I-mediated DNA Cleavage Activity Produced by Actinomycetes: Producing Organism,Fermentation, Isolation and Biological Activity.

1997 ◽  
Vol 50 (6) ◽  
pp. 490-495 ◽  
Author(s):  
NOBORU FUJII ◽  
FUTOSHI TANAKA ◽  
YOSHINORI YAMASHITA ◽  
TADASHI ASHIZAWA ◽  
SHIGERU CHIBA ◽  
...  
ChemInform ◽  
2010 ◽  
Vol 26 (11) ◽  
pp. no-no
Author(s):  
N. FUJII ◽  
Y. YAMASHITA ◽  
K. ANDO ◽  
T. AGATSUMA ◽  
Y. SAITOH ◽  
...  

1993 ◽  
Vol 46 (7) ◽  
pp. 1173-1174 ◽  
Author(s):  
NOBORU FUJII ◽  
YOSHINORI YAMASHITA ◽  
SHIGERU CHIBA ◽  
YOUICHI UOSAKI ◽  
YUTAKA SAITOH ◽  
...  

1994 ◽  
Vol 47 (8) ◽  
pp. 949-951 ◽  
Author(s):  
NOBORU FUJII ◽  
YOSHINORI YAMASHITA ◽  
KATSUHIKO ANDO ◽  
TSUTOMU AGATSUMA ◽  
YUTAKA SAITOH ◽  
...  

2010 ◽  
Vol 39 (3) ◽  
pp. 1014-1022 ◽  
Author(s):  
A. C. Gentry ◽  
S. Juul ◽  
C. Veigaard ◽  
B. R. Knudsen ◽  
N. Osheroff

2021 ◽  
pp. 174751982110458
Author(s):  
Jing Wang ◽  
Bin Huang ◽  
Liqiang Wang ◽  
Guijjuan Jiang ◽  
Jianxin Cheng ◽  
...  

Two novel oxovanadium(IV) complexes ([VO(hntdtsc)(BPIP)] and [VO(hntdtsc)(MOPIP)] (hntdtsc = 2-hydroxy-1-naphthaldehydethiosemicarbazone, BPIP = 2-(4-bromophenyl)-imidazo[4,5- f]-1,10-phenanthroline, MOPIP = 2-(4-methoxyphenyl)-imidazo[4,5- f]1,10-phenanthroline), are synthesized and characterized. Subsequently, the Methyl Thiazolyl Tetrazolium (MTT) assay is used to investigate the antitumor activity of the ligand and two complexes in vitro.The results indicate that both complexes could significantly inhibit selected tumor cells (SH-SY5Y, MCF-7, and SK-N-SH). In addition, the antibacterial activity of VO(hntdtsc)(BPIP) against Staphylococcus aureus is further investigated. Interestingly, VO(hntdtsc)(BPIP) can efficiently attenuate S. aureus growth and abrogate α-hemolysin secretion and biofilm formation. The plasmid DNA cleavage activity of both complexes is also investigated. The results suggest that supercoiled plasmid DNA is efficiently cleaved after treatment with each complex, which might contribute to the biological activity of these oxovanadium(IV) complexes.


1993 ◽  
Vol 46 (2) ◽  
pp. 235-240 ◽  
Author(s):  
YOUICHI UOSAKI ◽  
SHO-ZOU KAWADA ◽  
HIROFUMI NAKANO ◽  
YUTAKA SAITOH ◽  
HIROSHI SANO

1990 ◽  
Vol 43 (10) ◽  
pp. 1344-1346 ◽  
Author(s):  
YOSHINORI YAMASHITA ◽  
YUTAKA SAITOH ◽  
KATSUHIKO ANDO ◽  
KEIICHI TAKAHASHI ◽  
HIROE OHNO ◽  
...  

2013 ◽  
Vol 66 (11) ◽  
pp. 1406 ◽  
Author(s):  
Xiaojun He ◽  
Guang Yang ◽  
Xiaonan Sun ◽  
Lingjun Xie ◽  
Lifeng Tan

Two mixed-ligand ruthenium(ii) complexes [Ru(phen)2(cptcp)]2+ (Ru1; phen = 1,10-phenanthroline, cptcp = 2-(4-carbazol-9-yl-phenyl)-1H-1,3,7,8-tetraaza-cyclopenta-[l]-phenanthrene) and [Ru(phen)2(btcpc)]2+ (Ru2; btcpc = 9-butyl-6-(1H-1,3,7,8-tetraaza-cyclo-cyclopenta-[l]-phenanthren-2-yl)-9H-carbazole-3-carbaldehyde) have been synthesised and characterised. The DNA-binding behaviours of the two complexes have been investigated by using spectroscopic and viscosity measurements. Results suggest that the two complexes bind to DNA by intercalation. The photocleavage of plasmid pBR322 DNA indicates that Ru1 exhibits more effective DNA cleavage activity in comparison to that exhibited by Ru2 under the same conditions, and different cleavage mechanisms are determined. Topoisomerase inhibition and DNA strand passage assay confirm that Ru1 may act as an efficient dual inhibitor of topoisomerases I and II, whereas Ru2 may only act as a single inhibitor of topoisomerases II.


2005 ◽  
Vol 280 (46) ◽  
pp. 38489-38495 ◽  
Author(s):  
Bokun Cheng ◽  
Shikha Shukla ◽  
Sarinnapha Vasunilashorn ◽  
Somshuvra Mukhopadhyay ◽  
Yuk-Ching Tse-Dinh

Sign in / Sign up

Export Citation Format

Share Document